Our Focus
Atopic Dermatitis and Plaque Psoriasis
Chronic skin disorders that impact over 100 million people worldwide, with high unmet need for innovative topical therapies
Pipeline
TER-101
TER-101, a novel mechanism of action, targeting inflammatory pathways in skin disease